Lam Research is a publicly traded company in the Technology sector. This company operates across Technology and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 2 active Congressional signals mentioning Lam Research, including 2 bills. The current legislative sentiment leans bearish, with regulatory or policy headwinds potentially affecting performance.
HR8036 is a procedural bill that does not authorize any funding and is awaiting floor action. It expands interagency authority to propose export control rule changes and mandates a State Department review of China's military-civil fusion strategy. The primary market implication is the potential for future export restrictions on semiconductor equipment and AI chips to China, which poses a downside risk to AMAT, KLAC, LRCX, and NVDA. Defense primes (LMT, NOC, RTX, BA) see no near-term direct impact.
→ Increased potential for future rulemakings restricting semiconductor equipment exports to China
The License Monopoly Prevention Act of 2025 (S3200) is an early-stage Senate bill requiring competitive market reviews before BIS can issue exclusive export licenses for emerging technologies to Entity List entities. It has zero direct funding and no near-term market impact as it sits in committee with no scheduled hearing. The structural effect is procedural: it aims to prevent monopoly export licenses, which could modestly reduce pricing power for sole-source suppliers but improve market access for competitors.
→ Procedural review before granting exclusive export licenses for semiconductor etching and deposition equipment to single suppliers for foreign listed entities.